July 26, 2022

Thousands of patients to benefit

Thousands of people a year with advanced breast cancer will benefit from a life-extending drug that has been fast-tracked onto the frontline of NHS patient care.

The drug, alpelisib, will be used in combination with the hormone therapy, fulvestrant, to target the gene that causes fast-growing tumours.

Read more – NHSE & I (14/7/22)

Leave a Reply

Your email address will not be published. Required fields are marked *